{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:30:58Z","timestamp":1789392658976,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.oooo.2012.01.030","type":"journal-article","created":{"date-parts":[[2012,5,12]],"date-time":"2012-05-12T11:36:30Z","timestamp":1336822590000},"page":"e49-e56","source":"Crossref","is-referenced-by-count":17,"title":["Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series"],"prefix":"10.1016","volume":"114","author":[{"given":"Konrad","family":"Staines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Hampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2012.01.030_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2012.01.030_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","article-title":"The pathophysiology of bullous pemphigoid","volume":"33","author":"Kasperkiewicz","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.oooo.2012.01.030_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11882-005-0078-9","article-title":"Ocular cicatricial pemphigoid: manifestations and management","volume":"5","author":"Chang","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.oooo.2012.01.030_bib4","first-page":"191","article-title":"Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy","volume":"17","author":"Bruch-Gerharz","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.oooo.2012.01.030_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004056","article-title":"Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita","author":"Kirtschig","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.oooo.2012.01.030_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oooo.2012.01.030_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0151-9638(05)79188-2","article-title":"Cicatricial pemphigoid: treatment with mycophenolate mofetil","volume":"132","author":"Ingen-Housz-Oro","year":"2005","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.oooo.2012.01.030_bib8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bjo.2006.092528","article-title":"Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa ocular cicatricial pemphigoid: manifestations and management","volume":"90","author":"Higgins","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oooo.2012.01.030_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1067\/mjd.2001.114746","article-title":"Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent (mycophenolate mofetil as effective therapy option in scarring pemphigoid)","volume":"45","author":"Megahed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.oooo.2012.01.030_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.142.11.1457","article-title":"Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients","volume":"142","author":"Canizares","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.oooo.2012.01.030_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/00016350152509256","article-title":"Immunodiagnosis of pemphigus and mucous membrane pemphigoid","volume":"59","author":"Challacombe","year":"2001","journal-title":"Acta Odontol Scand"},{"issue":"10","key":"10.1016\/j.oooo.2012.01.030_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002292.pub3","article-title":"Interventions for bullous pemphigoid","author":"Kirtschig","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.oooo.2012.01.030_bib13","first-page":"201","article-title":"Dapsone therapy of cicatricial pemphigoid","volume":"7","author":"Rogers","year":"1988","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.oooo.2012.01.030_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000075040","article-title":"Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera","volume":"208","author":"Joly","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.oooo.2012.01.030_bib15","article-title":"Pemphigoid diseases: pathogenesis, diagnosis, and treatment","author":"Kasperkiewicz","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.oooo.2012.01.030_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00105-003-0595-1","article-title":"Mycophenolate mofetil as effective therapy option in scarring pemphigoid","volume":"54","author":"Elser","year":"2003","journal-title":"Hautarzt"},{"key":"10.1016\/j.oooo.2012.01.030_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.healun.2006.06.010","article-title":"Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation","volume":"25","author":"O'Neill","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.oooo.2012.01.030_bib18","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/TP.0b013e31818b62c8","article-title":"Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation","volume":"86","author":"Neff","year":"2008","journal-title":"Transplantation"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440312001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440312001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T08:24:51Z","timestamp":1542961491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440312001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S2212440312001150"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2012.01.030","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}